American Century Companies’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,124
| Closed | -$211K | – | 2933 |
|
|
2024
Q2 | $211K | Sell |
10,124
-49,942
| -83% | -$1.04M | ﹤0.01% | 2713 |
|
|
2024
Q1 | $883K | Buy |
60,066
+16,776
| +39% | +$247K | ﹤0.01% | 2202 |
|
|
2023
Q4 | $447K | Buy |
43,290
+12,451
| +40% | +$128K | ﹤0.01% | 2405 |
|
|
2023
Q3 | $242K | Buy |
30,839
+7,776
| +34% | +$61.1K | ﹤0.01% | 2527 |
|
|
2023
Q2 | $230K | Buy |
23,063
+10,531
| +84% | +$105K | ﹤0.01% | 2491 |
|
|
2023
Q1 | $108K | Buy |
12,532
+2,200
| +21% | +$19K | ﹤0.01% | 2537 |
|
|
2022
Q4 | $113K | Buy |
+10,332
| New | +$113K | ﹤0.01% | 2438 |
|